Ardelyx Inc

ARDXStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$3.39

Today

+1.5%

YTD

-42.6%

About

Founded in 2007, Ardelyx Inc is a biopharmaceutical company that develops medicines to treat cardiorenal diseases. Operating internationally, the company has its headquarters in Fremont, California. Ardelyx stock is listed using the ARDX ticker on the NASDAQ GM stock exchange. Use your eToro watchlist to find out more about ARDX stock news.

Price chart

Closing price history for ARDX (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-14.77

P/S (TTM)1.84

P/B (TTM)5.58

Market cap$832.29M

Cap tierSmall-cap

Industry avg P/E-7.37

Profitability

Gross margin93.62%

EBIT margin-7.86%

Net margin-13.83%

ROE-38.61%

ROA-10.68%

Earnings & Revenue

Revenue (TTM)$450.89M

Revenue growth (1Y)+16.8%

EPS (TTM)-$0.23

Free cash flow$-17.92M

Total debt$256.19M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)0.97

Employees489

Next earnings29 Oct '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.